AN2 Therapeutics
ANTX
ANTX
37 hedge funds and large institutions have $20.1M invested in AN2 Therapeutics in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.34% more ownership
Funds ownership: 45.29% → 48.62% (+3.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
37
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.81M | |
| 2 | +$582K | |
| 3 | +$562K | |
| 4 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$545K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$510K |
Top Sellers
| 1 | -$2.14M | |
| 2 | -$1.66M | |
| 3 | -$477K | |
| 4 |
Millennium Management
New York
|
-$260K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$84.9K |